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We always strive to minimize the impact of bias in observational studies due to possible 
nonrandom treatment assignment. Propensity score and inverse weighting methods bo  attempt 
to achieve this goal. Inverse probability weighting is the method based on Horvitz and 
Thompson (1952) while propensity score is based on Rosenbaum and Rubin (1983). Because 
they are the most prevalent methods in longitudinal studies, these methods should be evaluat d 
to find out which is better in reducing bias and producing accurate estimates. However, there are 
few studies comparing the two approaches. In a study of theory and simulated data, Ertefaie and 
Stephens (2010) demonstrated that, in simple cases, multivariate generalized propensity score 
(MGPS) routinely produced estimators with lower Mean-Square Error (MSE) when compared to 
inverse probability weighting (IPW). In the same paper, however, they were unable to show the 
same result in a longitudinal dataset. In this paper, I will perform similar comparisons in the 
treatment effect hazard ratio estimates as well as the efficiency of the estimates, specifically the 
variance of the two methods in an observational longitudinal public health study. I will only 
compare the direct effect of treatment, or the unconfounded and unmediated effect on expected 
response, since this is the only place where Propensity score and Inverse Weighting methods are 
comparable, and demonstrate that PS may not be the best method of analysis for reducing bias in 
longitudinal time-to-event studies, despite theoretical studies to the contrary. The results show 
that the treatment effect hazard ratio estimates with the two approaches are indistinguishable, 








In a perfect world, the designers of experimental studies and controlled clinical trials 
would attempt to randomly assign subjects or patients to a condition or treatment group. 
However, in real-life studies, the “assignment” of a person to a treatment group or condition is 
usually not entirely random, unless specifically designed. Observational studies are, by design, 
not likely to be random in group or condition “assignment”. Prominent statisticians have spent 
years inventing and introducing methods to reduce the biases in experimental studies. And in the 
recent decade, competing methods have been slowly overtaken in popularity by weighting 
methods. 
 Even though inverse probability weighting (IPW) method was first introduced in the 
1950s (Horvitz and Thompson, 1952), it was, for an extended period, widely considered 
inefficient relative to likelihood based methods (Clayton et al. 1998), and resulted in estimat  
sensitive to the precise form of the model for the probability of response (Littl and Rubin, 
1987), Robins and colleagues proposed improved IPW estimates that mitigated both problems in 
a series of papers in the 1990s, such as Robins et al. (1995), Robins and Rotnizky (1995), and 
Scharfstein et al (1999). IPW is a weight equal to the inverse of the probability of response by 
treatment group. 
Another method of reducing bias is the propensity score (PS). PS, first proposed by 
Rosenbaum and Rubin (1983, 84), is defined as the conditional probability of receiving the 
treatment given pre-treatment covariates. IPW and PS are thus constructed in similar fashion. 
First, a model for treatment group or condition is fitted. The resulting conditional model for the 




Despite the theoretical similarity of the two bias-reducing methods, there have been very 
few direct comparison studies between them. Ertefaie and Stephens (2010) found that PS 
outperformed IPW in mean squared error (MSE) in single and multiple interval simulation 
studies. However, no preference was found for either method using real data from Mother’s 
Stress and Children’s Morbidity Study, a small (N=167) longitudinal study. Tan (2007) also 
could not show superior efficiency of an IPW or IPW-like estimator over that of a regression 
estimator based on controlling for all pretreatment variables, essentially a PS estimator. Hirano et 
al. (2003) found the two estimators to be asymptotically equivalent. 
In this paper, we compare PS and IPW in a large (n=5698) longitudinal time to event 
dataset from the Medicare Current Beneficiary Survey (MCBS). We will examine the 
performance indicators, such as the variance and MSE, of the estimators produced by the two 
methods for establishing the magnitude of the direct effect of treatment, without any of the 
confounding effects. The main focus is on direct effect of the treatment because it is th  only 
situation where IPW and PS methods can be directly compared. The hazard ratio estimates of all 
other potential covariates for the effect of covariates are interesting to discuss but not directly 




3.1 Propensity Score (PS) 
As previously discussed, propensity score is a method of reducing bias in treatment effect 
estimation. At its most basic form, PS is defined for binary treatment as  




where π(x) is the propensity score, Tr is treatment, and x is the covariate, by Rosenbaum and 
Rubin (1983) and is the most basic function of covariates that has the balancing property, which 
means treatment assignment is independent of covariates given the propensity score. This, of 
course, requires all confounding variables to be known as well as the existence of a real choice 
between treatment and control for each patient at the time of treatment selection, both critical 
criteria for what Rosenbaum and Rubin (1983) called the assumption of a strongly ignorable 
treatment assignment. 
To produce the least biased propensity score model, it is important to not only include 
covariates that are correlated with treatment but also those correlated with outcome, as doing so 
would decrease the precision of the treatment effect estimate (Brookhart et al, 2006) Variables 
whose removal result in insignificant changes in estimated treatment eff c  and an increase in 
precision are seen as unlikely confounders and can be safely removed from propensity model 
(Hill and Kleinbaum, 2000). The average treatment effect can be computed from propensity 
score estimates using iterated expectation 
µ = E[Y(1) – Y(0)] = Eπ(X){E[ Y(1)| π(X)] – E[Y(0)| π(X)]}  
where Eπ(X) is the expectation with respect to the distribution of π(X) in the entire population 
(Ertefaie and Stephens, 2010) 
 The propensity scores produced can be used to find a conditional estimate of treatment 
effects given propensity score π, over the distribution of π. This can be best accomplished 
through matching between treatment and control patients, stratification, or using the PS directly 
as a covariate in the regression. Matching protects against misspecification of the propensity 
model but can significantly reduce sample size. Many existing user-geneat d programs and 
macros with numerical matching algorithms exist for SAS and other statistic l analysis tools. 
 
 
Stratification is similar to matching in effectivenss w
lack of strong assumptions on time dependency of the effect of PS on the outcome. A quasi
standard of 5 strata exists for stratification based on the work of Cochran (1968). But Cochran 
also suggests that more than 5 strata should be used for larger datasets to further reduce 
imbalance. However, because stratification aims to produce treatment groups with similar 
probability of receiving treatment versus control, the individuals in the strata may be 
indistinguishable for further clinical decision making. (Curtis et al, 2007)
For our MCBS dataset, the 
an easy method to implement since the absolute standardized difference between the probability 
of outcome in the treated group and the probability of outc me in the untreated group can be 
determined (Austin 2008). But an incorrect
PS and outcome, such as assuming assignment to treatment group to be a pro
itself after controlling for other covariates,
results (Rosenbaum and Rubin, 1983).
and the second step of establishing functional r
be correct in order to correct bias.
 In a dataset with time-varying covariates, a generalized propensity score method is more 
appropriate. If we set Yij, Trij, and X
j, respectively, then we can find π
find, for every dose tr, 
and with it the E[Yij (tr) | πij (tr, X
of covariate Xij. 
6 
ithout the risk of losing subjects due to a 
 
estimated PS is used directly in the model as a covariate. It is 
 assumption about the functional relationship between 
gnostic factor by 
 can negate the benefits of PS and lead to biased 
 Therefore, both the first step of propensity score model 
el tionship between PS and the outcome need to 
 
ij, as the response, treatment, and covariates of unit 
ij as the propensity score. Moodie and Stephens (2010) then 
Yij (tr)  Trij | πij (tr, Xij), 
ij)] can be found as the unbiased estimate over the distribution 
-




 Any proposed propensity score model can be adequate as long as balance is achieved, 
that is, the distribution of covariates X for different values of treatment Tr for each strata of PS π 
is approximately balanced. While any score that achieve balance will provide unbiased estimates 
of the treatment effect, the variance depends strictly on the definition of the PS (Ertefaie and 
Stephens 2010). In this case, variance is obtained using the standard model-based variance 
estimate. The results for the propensity score method were generated by Ling Han, MD, MS of 
the Yale Program on Aging/Pepper Center Biostatistics Core. 
 
3.2  Inverse Probability Weighting (IPW) 
The basic idea of IPW is conceptually easy to grasp and to program. A simple example is 
presented by missingdata.org.uk (2012) 
Suppose we saw the following data, 
Group A B C 
Response 1 1 1 2 2 2 3 3 3 
 
then the average response is 2. However if we observed 
Group A B C 
Response 1 ? ? 2 2 2 ? 3 3 
 
then the average response is 13/6, which is biased. However, the probability of response is 1/3 in 
group A, 1 in group B and 2/3 in group C. We can therefore calculate a weighted average, where 
each observation is weighted by 1/{Probability of response}: 




Thus, in this case, inverse probability weighting (IPW) has eliminated the bias
adjusting for measured data. More 
estimates, just less of them. 
We can then expand the idea for treatment that is confounde
treatment parameter can even be obtained using a weighted analysis, assuming there are no 
unmeasured confounders. For a binary treatment (treated/untreated or treated/placebo), much like 
beta blocker use we have in our present 
assigned, where 
ηi = 
where tri is the observed binary treatment and 
weight, essentially an ideological extension of 
used in a weighted regression of Y on observed treatm nt T and components of X
an average treatment effect.  
 While the estimated weight is 
highly variable. This can be amended by stabilization, replacing the numerator of the weight with 
the marginal probability of receiving the treatment. The resulting stabilized weight
Robins (1997) is 
where (tri, xi) are treatment and confounders as previously describ d
density function. The further expansion of this idea for multilevel and continuous treatment is 
discussed by Robins et al (2000), where the stabilized we
8 
generally we will see it may still give biased parameter 
d. Unbiased estimates of the 
data, for each subject i he weight wi = 1 + e
logit{ p(Tr = tri | X = xi)} = β0 + β1xi 
xi the observed confounder for subject 
the propensity score discussed earlier,
theoretically asymptotically unbiased, in practice 
swi = f (tri) / f (tri | xi) 
e , and f is the probability 
ight becomes  




 can then be 
 in order to find 
wi is 




provided that the initial logistic model calculating the weight is correctly specified. The Marginal 
structural models (MSM), a class of causal models for the estimation of the causal effect of a 
time-dependent exposure in the presence of time-dependent covariates that may be 
simultaneously confounder and intermediate variables from observational data, are consistently 
estimated by IPW estimators (Robins et al, 2000). 
 The IPW we already introduced, however, only accounts for confounders at baseline. To 
adjust for time-varying aspect of potential covariates, stabilized IPW for patient i at visit j are the 
product of inverse probability of exposure defined as  
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where 0 is a vector of zeroes, 
 a vector of fixed baseline variables and 
 a vector of time-
varying variables. The denominator adjusts for bias while the numerator stabilizes. Therefore, 
unstabilized IPW for the same patients are just 
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The magnitude of nonpositivity bias increases with the number of time points and decreases with 
the use of appropriately stabilized weights (Cole and Hernán, 2008). In most cases, lack of 
stabilization results in larger variance estimates. Therefore, stabilization is generally preferred in 
order to achieve greater efficiency for no real cost.  
IPW adjusted time-to-event analysis is a derivative of using such weights in controlling 
of confounding in analyzing survival data, as described by Robins et al (2000). A Cox regression 
model, weighted by estimated stabilized weights, accounts for cofounding by the covariate 
vector X because the “pseudo-population” created by weighting on the covariate X are unrelated 




adjusting our IPW for the inverse probability of censoring. Variance of the hazard ratio estimate, 
obtained through a Cox model, is normally estimated through the robust variance estimator of 
Lin and Wei (1989) so that variance estimate is valid under null hypothesis and provides 
conservative confidence interval range. However, in this case we must utilize the sandwich 
estimator, similar to generalized estimating equations proposed by Zeger et al. (1988), 
accounting for the variability in estimating the weights. Based on Carpenter a d Kenward 
(2006), if we write the estimating equation for β as Σni=1 µi(β) = 0, and the estimating equation for 
the logistic regression on the probability of observing X1i, parameterized by α, as Σ
n
i=1 νi(α) = 0. 
Then, let wi(β, α) = (µ

















SAS programming is used in both data transformation and analysis with this method. 
 
4 Data and Analysis 
4.1 MCBS 
 The dataset used in the analysis is a subset of 3752 patients between 2002 and 2006 in the 
large Medicare Current Beneficiary Survey (MCBS) that focuses on the effect o  beta-blocker 
usage in patients with co-existing coronary artery disease and COPD or after myocardial 
infarction (MI) patients for combating adverse cardiovascular events. Even though randomized 




according to the meta-analysis of Freemantle et al. (1999), this is an excellent opportunity to 
study the overall cardio-protective effectiveness of binary beta-blocker use in a strongly 
representative subset of the overall elderly population regardless of previous MIs. The subset 
includes patients from age 65 to 103, with the mean age being 78.39 years and median age 78, 
which is exactly what one would expect of the Medicare utilizing population.  
Each individual had a variety of cardiovascular risk factors recorded, includig sex, race, 
prior myocardial infarction, stent CABG, smoking status, etc. Based on enrollment dat , each 
patient was observed for an entire year with no repeated measurement of the covariates and only 
seen when an adverse cardiac event occurs or at the end of the observational period. 1946 of the 
uncensored patients were followed for a further year with new measurements of the covariates 
under similar conditions. We use these data to determine treatment effect of beta-blocker use on 
cardiac health. Logistic regressions are used to fit the model for weights and propensity score 
over each interval over all relevant covariates, including the cardiovascular risk factors 
introduced earlier, as well as mobility, hypertension, diabetes, oral corticosteroid use, prior 
stroke, congenital heart defect, dementia, end stage renal disease, and a few others. 
 
4.2 PS versus stabilized and unstabilized IPW 
The resulting logistic models that include all the possible covariates, collectively shown 
as xij, for unit i and time j are 
logit{ p(tri1 = 1)} = α0 + α1xi1 
logit{ p(trij = 1)} = β0 + β1tri(t-1) + β2ci(t-1) + β3xi1 




 We can then model our binary response, adverse cardiac symptoms, using cox regression 
with beta-blocker usage, all relevant time-varying covariates, and either PS as a covariate or 
weighting by IPW of treatment. The Cox proportional hazard model must then be generalized in 
order to fit the time-varying covariates. This is easily handled in theory for Cox regression 
models and in practice with modern statistical programming software such a SAS. Ties are 
resolved using the standard Breslow method for Cox regression and life model (Breslow, 1974). 
We compare the estimates and the variance of treatment effect of beta-blockers using PS, 
stabilized IPW, as well as unstabilized IPW. The results of the analysis re presented in Table 1 
below.  
Table 1: Parameters estimates based on IPW and PS for MCBS adverse cardiac events 
study. 
  
Hazard Ratio Estimate Standard Error 




No Covariates 0.975 0.06411 (0.861, 1.105) 
All Covariates 0.985 0.08709 (0.830, 1.168) 
Stabilized 
IPW 
No Covariates 0.984 0.11878 (0.780, 1.242) 
All Covariates 1.029 0.11059 (0.828, 1.278) 
PS 1.033 0.07487 (0.892, 1.197) 
* Sandwich variance estimate used for all IPW method variances 
^ Hazard Ratio Estimate compares beta-blocker users vs nonusers 
 
 We can see that the treatment effects are all not significant and very similar to each other. 
Because of the consistent overlap between estimated treatment effect confidence interval 
regardless of any of the methods listed, it is difficult to say that one is preferable to another in 
terms of estimation efficiency. In fact, even the general rule that stabilized IPW has lower 
variance was not true in our case. Adjusting for covariates did not make much of a difference in 
unstabilized IPW in terms of the hazard ratio estimate for beta-blocker users versus nonusers. 




ratio estimate. Unfortunately, the difference was still rather small and within the range of the 
confidence interval. 
 
 4.3 Bootstrap 
 To more accurately access the precision of the hazard ratio estimates of th  treatment 
effect of beta-blocker use, we can use bootstrapping to find standard error. A bootstrap sample is 
an independent random sample of size n taken from dataset x with replacement. The bootstrap 
replication of statistic <= = s(x) is <=> = s(?>) and the bootstrap estimate of standard error is the 
observed standard deviation of repeated bootstrap replications. (Efron and Tibshirani, 1993) As 
the number of independent samples approaches infinity, <=> is approximately normally distributed 
and the bootstrap estimate of standard error approaches the estimate of the actual sample 
standard error. Precisely, the bootstrap estimate of standard error is calculated thusly, 
@AB  C∑ DE0>FE0>.GHF.  , where <=>.    ∑ E0>FF.  . 
For our data, we ran k=100 bootstrap sampling of the original dataset through the same models. 
Table 2 illustrates the comparison between model estimates and bootstrap estim tes of hazard 
ratio for beta-blocker users versus nonusers and standard errors for all methods in Table 1. 
Table 2: Comparison between model estimates and bootstrap estimates of hazard ratio for 












No Covariates 0.975 0.06411 0.976 0.06598 
All Covariates 0.985 0.08709 0.989 0.07608 
Stabilized IPW 
No Covariates 0.984 0.11878 0.983 0.07895 
All Covariates 1.029 0.11059 1.034 0.10037 
PS 1.033 0.07487 1.037 0.07877 




^ Hazard Ratio Estimates are for beta-blocker users versus nonusers 
 
We can see here that bootstrapped hazard ratio estimates and standard errors are very 
close to the estimates the model of the original dataset produced. One noticeable difference was 
in the standard error of the unadjusted treatment effect of beta-blocker use, where the standard 
error dropped from a high of 0.11878 to be more in line with other standard errors. More 
importantly, we can state that the standard error of the treatment effect adjus ed for all important 
covariates with the stabilized IPW method is higher than that through other methods and 
therefore less efficient in this case. 
 
4.4 Truncated IPW 
We may further adjust the IPW models with truncation methods as suggested by Cole and 
Hernán (2008). They indicate that the choice of the model used to construct weights may impact 
the results of the marginal structural model. This choice is based on an informal bias-variance 
tradeoff between inclusion of a sufficient number of flexibly modeled confounders in the weight 
model and well-behaved weights. Truncation methods allow us to explore this trade-off nd can 
give us a more refined comparison between the hazard ratio for beta-blocker users ver us 
nonusers and variance estimates obtained through stabilized and unstabilized IPWs. The simplest 
way to explore such a tradeoff is through progressive truncation, developed by Kish (1992). In 
this method, weights are truncated by resetting the values of weights grea er or less than 
percentile p(100-p) to the value of the weights at percentile p(100-p). The comparison of 
truncation-adjusted IPW between stabilized and unstabilized weights for our study is presented 





Table 3: Comparison of truncated IPW between stabilized and unstabilized weights for 
MCBS adverse cardiac events study. 
 
Truncated Percentile Mean (SD) Min Max Hazard Ratio Estimate SE 
Unstabilized 
IPW 
0, 100 1.18 (0.68) 0.11 11.46 0.985 0.0871 
1, 99 1.16 (0.54) 0.67 4.04 0.967 0.0795 
5, 95 0.95 (0.35) 0.86 2.38 0.951 0.0779 
10, 90 1.07 (0.21) 0.91 1.64 0.956 0.0743 
25, 75 1.01 (0.03) 0.97 1.05 0.949 0.0735 
50, 50 1.02 (0.00) 1.02 1.02 0.948 0.0734 
Stabilized 
IPW 
0, 100 0.42 (0.31) 0.01 4.48 1.029 0.1106 
1, 99 0.41 (0.26) 0.05 1.58 0.999 0.0981 
5, 95 0.40 (0.21) 0.10 0.93 0.983 0.0899 
10, 90 0.38 (0.16) 0.14 0.64 0.978 0.0830 
25, 75 0.37 (0.11) 0.23 0.51 0.973 0.0762 
50, 50 0.39 (0.00) 0.39 0.39 0.948 0.0734 
* Sandwich variance estimate used for all IPW method variances  
^ Hazard Ratio Estimates are for beta-blocker users versus nonusers 
  
Here the first row of each section corresponds to the marginal structure model adjusted 
for covariates for unstabilized and stabilized weight, respectively. Similarly, the last row of each 
section corresponds to the previously not shown baseline-adjusted model, which has a weight of 
1 for every subject, is why the hazard ratio estimates are the same with either method. We can 
see that precision of the estimate increases as truncation increases. However, bias also increases 
since we are truncating more of the weights. Therefore, in this case and assuming the marginal 
structural model estimate is unbiased, it is unlikely for the small gain in precision to outweigh 
the increase in bias.  
 
5 Discussion and Summary 
Past studies, such as Chamberlain (1987), Hahn (1998), Hirano et al. (2003), and Ertefaie 




method over inverse probability weighting method in MSE, variance, efficiency, and bis 
removal, assuming correct model specification in general longitudinal studie . But no simulation 
seems to exist for show the same for longitudinal time-to-event data. A real dataset like our study 
on the MCBS impact of beta-blocker use on adverse heart event data shows that, in a large 
empirical public health dataset with longitudinal time-to-event binary outcome, could not 
conclusively determine PS method as having better performance than IPW methods. We were 
able to show that PS results in a numeric variance estimate of the treatment effect hazard ratio 
estimate that is similar to that using the unstabilized IPW method, while maintaining a hazard 
ratio estimate that is more similar to that using the stabilized IPW.  
Unfortunately, there were significant overlaps in the confidence interval estimates, which 
did not allow a conclusion on the statistical superiority of one method versus the other, especially 
without simulation to show the accuracy of the estimates. We would have also preferred larger 
resampling of bootstrapping for the precision analysis. However, hardware limitations restricted 
the bootstrapping capacity of SAS for such a large dataset and 25 to 200 replications is generally 
seem as sufficient for estimating a standard error through bootstrapping. The treatment in our 
study, beta-blocker use, did not have a significant treatment effect on adverse cardiac events. We 
cannot be sure that a study with a significant treatment effect would not result in clearer 
distinction between PS and IPW methods according to theoretical projections. Furthermore, the 
limited of time points limited the usefulness of the stabilized IPW method. Future analyses with 
multiple time points could be of interest.  
Direct implementation of PS as a covariate in the model is a simpler process than the 
multiple modeling and calculation required for both truncated and stabilized IPW. However, the 




versus untreated, whereas the marginal structural method with IPW allowsfor the estimation of 
effects of other covariates as well, which tells researchers additional information about the 
dataset. We would have also liked to include the same comparison with the PS matching met od.
But computational limits eliminated that plan. Therefore the comparison between PS and IPW 
methods is not necessarily simply for theoretical efficiency and accury but also for whether the 
study is only interested in the treatment or other covariates as well. Furthermore, current 
developments in doubly robust IPW and potential developments in PS that allows for estimation 
of total effects could improve the current weakness in each method, respectively, and make for 
interesting future comparisons. 
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